Temasek Holdings
BEAM icon

Temasek Holdings’s Beam Therapeutics BEAM Stock Holding History

Temasek Holdings’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,812,972
Closed -$35.4M – 134
2025
Q1 		$35.4M Hold
1,812,972
– – 0.14% 66
2024
Q4 		$45M Hold
1,812,972
– – 0.18% 53
2024
Q3 		$44.4M Hold
1,812,972
– – 0.18% 59
2024
Q2 		$42.5M Hold
1,812,972
– – 0.2% 47
2024
Q1 		$59.9M Sell
1,812,972
-1,263,145
-41% -$39.4M 0.33% 42
2023
Q4 		$83.7M Sell
3,076,117
-1,241,672
-29% -$30.8M 0.47% 36
2023
Q3 		$104M Hold
4,317,789
– – 0.62% 34
2023
Q2 		$138M Buy
4,317,789
+223,277
+5% +$7.25M 0.8% 30
2023
Q1 		$125M Buy
4,094,512
+1,216,215
+42% +$48M 0.74% 31
2022
Q4 		$113M Buy
2,878,297
+12,029
+0.4% +$539K 0.66% 33
2022
Q3 		$137M Sell
2,866,268
-1,092,944
-28% -$62.3M 0.82% 33
2022
Q2 		$153M Hold
3,959,212
– – 0.84% 29
2022
Q1 		$227M Buy
3,959,212
+501,827
+15% +$32.9M 0.96% 31
2021
Q4 		$276M Hold
3,457,385
– – 0.99% 26
2021
Q3 		$301M Hold
3,457,385
– – 1.05% 23
2021
Q2 		$445M Buy
3,457,385
+51,372
+2% +$4.09M 1.49% 18
2021
Q1 		$273M Buy
3,406,013
+51,372
+2% +$4.89M 1.07% 22
2020
Q4 		$274M Hold
3,354,641
– – 1.18% 20
2020
Q3 		$82.6M Hold
3,354,641
– – 0.42% 33
2020
Q2 		$93.9M Hold
3,354,641
– – 0.56% 29
2020
Q1 		$60.4M Buy
+3,354,641
New +$72.9M 0.45% 29

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Temasek Holdings's BEAM Position: Q2 2025 in Review

Temasek Holdings sold out of Beam Therapeutics (BEAM) in Q2 2025, closing a stake of 1,812,972 shares — an estimated $35.4M sold.

Temasek Holdings first reported a position in BEAM in Q1 2020 and held it in 21 quarters. The position peaked at $445M in Q2 2021. 216 funds tracked by Wall St. Rank hold BEAM as of Q2 2025.

  • Temasek Holdings reported no remaining Beam Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Temasek Holdings sold 1,812,972 Beam Therapeutics shares in Q2 2025, an estimated $35.4M.
  • Temasek Holdings first reported a position in Beam Therapeutics in Q1 2020 and held it in 21 quarters.
  • Temasek Holdings's Beam Therapeutics position peaked at $445M in Q2 2021.
  • 216 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2025.

Based on Temasek Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.